BioRem Inc.

TSXV:BRM Stock Report

Market Cap: CA$50.6m

BioRem Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Derek Webb

Chief executive officer

CA$426.5k

Total compensation

CEO salary percentage58.8%
CEO tenure10yrs
CEO ownership1.9%
Management average tenure6.5yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

Investors Continue Waiting On Sidelines For BioRem Inc. (CVE:BRM)

Oct 11
Investors Continue Waiting On Sidelines For BioRem Inc. (CVE:BRM)

Solid Earnings May Not Tell The Whole Story For BioRem (CVE:BRM)

Apr 19
Solid Earnings May Not Tell The Whole Story For BioRem (CVE:BRM)

BioRem Inc. (CVE:BRM) Soars 35% But It's A Story Of Risk Vs Reward

Apr 12
BioRem Inc. (CVE:BRM) Soars 35% But It's A Story Of Risk Vs Reward

BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet

Jan 25
BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet

Is BioRem (CVE:BRM) Using Too Much Debt?

Aug 26
Is BioRem (CVE:BRM) Using Too Much Debt?

Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly

Mar 23
Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly

BioRem (CVE:BRM) Could Easily Take On More Debt

Aug 25
BioRem (CVE:BRM) Could Easily Take On More Debt

These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well

May 20
These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well

Here's What's Concerning About BIOREM's (CVE:BRM) Returns On Capital

Jan 26
Here's What's Concerning About BIOREM's (CVE:BRM) Returns On Capital

Key Things To Understand About BIOREM's (CVE:BRM) CEO Pay Cheque

Nov 23
Key Things To Understand About BIOREM's (CVE:BRM) CEO Pay Cheque

CEO Compensation Analysis

How has Derek Webb's remuneration changed compared to BioRem's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

CA$5m

Jun 30 2024n/an/a

CA$4m

Mar 31 2024n/an/a

CA$3m

Dec 31 2023CA$427kCA$251k

CA$2m

Sep 30 2023n/an/a

CA$641k

Jun 30 2023n/an/a

CA$899k

Mar 31 2023n/an/a

CA$1m

Dec 31 2022CA$535kCA$251k

CA$2m

Sep 30 2022n/an/a

CA$2m

Jun 30 2022n/an/a

CA$2m

Mar 31 2022n/an/a

CA$2m

Dec 31 2021CA$427kCA$251k

CA$1m

Sep 30 2021n/an/a

CA$854k

Jun 30 2021n/an/a

CA$1m

Mar 31 2021n/an/a

CA$1m

Dec 31 2020CA$249kCA$242k

CA$2m

Sep 30 2020n/an/a

-CA$1m

Jun 30 2020n/an/a

-CA$640k

Mar 31 2020n/an/a

-CA$721k

Dec 31 2019CA$244kCA$235k

-CA$1m

Sep 30 2019n/an/a

CA$5m

Jun 30 2019n/an/a

CA$5m

Mar 31 2019n/an/a

CA$5m

Dec 31 2018CA$344kCA$235k

CA$5m

Sep 30 2018n/an/a

CA$1m

Jun 30 2018n/an/a

CA$2m

Mar 31 2018n/an/a

CA$1m

Dec 31 2017CA$610kCA$235k

CA$2m

Compensation vs Market: Derek's total compensation ($USD296.80K) is above average for companies of similar size in the Canadian market ($USD164.16K).

Compensation vs Earnings: Derek's compensation has been consistent with company performance over the past year.

CEO

Derek Webb

10yrs

Tenure

CA$426,520

Compensation

Mr. Derek S. Webb, P.Eng., MBA has been the Chief Executive Officer and President of BIOREM Inc. since December 17, 2014. Mr. Webb served as Executive Vice President of BIOREM Inc. from January 2012 to Dec...

Leadership Team

NamePositionTenureCompensationOwnership
Derek Webb
CEO, President & Director10yrsCA$426.52k1.94%
CA$ 980.8k
Douglas Newman
CFO & Secretary12.8yrsCA$252.30kno data
Dan Costello
Director of Operations3yrsno datano data
Mark Smit
Director of Technical Services3yrsno datano data

6.5yrs

Average Tenure

Experienced Management: BRM's management team is seasoned and experienced (6.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Derek Webb
CEO, President & Director10yrsCA$426.52k1.94%
CA$ 980.8k
William White
Independent Chairman of the Board4.5yrsCA$56.70kno data
Alex Gill
Independent Director4.5yrsCA$46.95kno data

4.5yrs

Average Tenure

Experienced Board: BRM's board of directors are considered experienced (4.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:54
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioRem Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution